Treatment with peptide mimetics reduced the number of bacteria present on the surface of the airways (shown in red) in a cystic fibrosis model.
Image Credit: © UNIGE—Marc Chanson
Scientific Frontline: Extended "At a Glance" Summary: Cystic Fibrosis Respiratory Infections
The Core Concept: Researchers have identified that the abnormal prolonged activation of connexin 43, a cell-communication protein, disrupts airway cellular organization in cystic fibrosis patients, creating "anchor points" that allow pathogenic bacteria to adhere and cause chronic infections.
Key Distinction/Mechanism: While current treatments often focus on managing the symptoms of infection, this research targets the underlying structural vulnerability of the respiratory epithelium. By inhibiting connexin 43 activity using mimetic peptides—synthetic molecules already utilized in dermatology and oncology—the structural integrity of the airway cells is restored, physically preventing bacterial colonization.
Major Frameworks/Components:
- Connexin 43: A protein normally responsible for cell communication and regeneration; its persistent abnormal activity in cystic fibrosis degrades tissue integrity.
- Mimetic Peptides: Short synthetic molecules that successfully block the harmful activity of connexin 43.
- 3D Cellular Modeling: Researchers utilized 3D models of cells derived from human lungs to observe these mechanisms and test the peptide mimetics.
Branch of Science: Cell Physiology, Molecular Biology, Pulmonology, Genetics.
Future Application: The use of mimetic peptides represents a potential new therapeutic avenue to proactively protect airway integrity and limit life-threatening chronic respiratory infections in cystic fibrosis patients.
Why It Matters: Chronic pulmonary infections remain a primary challenge for individuals with cystic fibrosis despite recent therapeutic advances. This mechanism offers a way to address the physiological root of the vulnerability rather than simply treating established infections.
A UNIGE team has succeeded in restoring the defective respiratory protective barrier in people with this rare genetic disease.
Cystic fibrosis, one of the most common genetic diseases in Switzerland, promotes chronic bacterial infections by impairing the protective barrier of the airways. Scientists at the University of Geneva (UNIGE) have discovered that this dysfunction is caused by the abnormal activation of a protein, connexin 43, which disrupts cellular organization and compromises the integrity of the airways. The team has not only shed light on this molecular mechanism using 3D models of cells derived from human lungs but has also succeeded in correcting the defect using molecules already undergoing clinical trials in dermatology and oncology. Preventing pathogenic bacteria from attaching to the airways of people with cystic fibrosis could therefore help limit serious complications. These findings are published in the journal Communications Biology.
Despite significant therapeutic advances, chronic pulmonary infections persist in many patients with cystic fibrosis. Eradicating respiratory pathogens, therefore, remains a major challenge. In previous work, the team led by Marc Chanson, a full professor in the Department of Cell Physiology and Metabolism, the Department of Pediatrics, Gynecology, and Obstetrics, and the Geneva Center for Inflammation Research at the UNIGE Faculty of Medicine, discovered that this vulnerability to infection stemmed from abnormal adhesion sites on the surface of respiratory cells—true “anchor points” to which bacteria attach firmly. “But to develop treatments, we first needed to understand the underlying mechanisms,” explains Chanson.
A Protein at the Origin of Bacterial Anchor Points
Connexin 43 is a protein known for its role in communication between cells, a process essential to the functioning of tissues and organs. In the airways, it is normally active only when cells need to regenerate. In people with cystic fibrosis, however, it remains abnormally active, triggering a cascade of dysfunctions.
“Using 3D models of cells derived from human lungs, we discovered that prolonged connexin 43 activity alters cell communication, disrupts cell orientation, and progressively disorganizes tissue integrity,” says Mehdi Badaoui, senior lecturer in the Department of Cell Physiology and Metabolism at the UNIGE Faculty of Medicine and first author of the study. “It then promotes the formation of the anchor points to which the bacteria responsible for respiratory infections attach.”
By targeting the deep mechanisms underlying airway dysfunction, our results could offer an additional treatment approach.
Restoring the Integrity of the Airways
By blocking connexin 43 activity in their 3D models, the research team was able to restore cell orientation, reestablish the spatial organization of cells, and prevent the formation of anchor points. “Mimetic peptides—short synthetic molecules already used to promote wound healing—drastically reduced the ability of bacteria to colonize respiratory cells,” explains Badaoui.
“These findings demonstrate that the regulation of cell communication by connexin 43 is a fundamental element in maintaining pulmonary defense,” concludes Chanson. “By targeting the deep mechanisms underlying airway dysfunction, our results could offer an additional treatment approach.”
Published in journal: Communications Biology
Title: Cx43 levels guide apicobasal polarity in regenerating airway epithelial cells
Authors: Mehdi Badaoui, Alexandre Luscher, Mengjie Ma, Marc Bacchetta, Christian van Delden, Thilo Köhler, Arantxa Tabernero, and Marc Chanson
Source/Credit: Université de Genève
Edited by: Scientific Frontline
Reference Number: mbio090826_01